The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Examining age-specific trends in the incidence of anorectal cancer associated with human papillomavirus in the United States.
 
Atharva Rohatgi
No Relationships to Disclose
 
Nathan Tran
Employment - UCSF / Sutter Health
 
Chloe Chan
Employment - Sutter Health (I)
 
Kriti Bomb
No Relationships to Disclose
 
Nora Tillmanns
Employment - Astrazeneca (I)
Leadership - Saint Francis Hospital and West Clinic Cancer and Research Institute
Honoraria - GlaxoSmithKline (I)
Consulting or Advisory Role - Informed & Merck & GOG partners (I)
Speakers' Bureau - Speakers Bureau for Astrazeneca (I)
Research Funding - Informed
Travel, Accommodations, Expenses - GlaxoSmithKline; GlaxoSmithKline (I); Informed; Informed (I)
Other Relationship - Medical Board for the State of Tennessee (I)
 
Qiao Ruan
No Relationships to Disclose
 
Daniel Kapp
No Relationships to Disclose
 
Cheng-I Liao
No Relationships to Disclose
 
John Chan
Honoraria - Abbvie; AstraZeneca; Eisai; Genmab/Seagen; GlaxoSmithKline/Tesaro; Immunogen; Merck; Myriad Genetics; Pfizer
Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Daiichi Sankyo; Eisai; Ethicon; Immunogen; Mersana; moon surgical; Myriad Genetics; Pfizer; Roche/Genentech; Seagen; Tesaro/GSK
Speakers' Bureau - AstraZeneca; Genmab/Seagen; GlaxoSmithKline/Tesaro; Immunogen; Myriad Genetics
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Eisai; Ethicon; Genmab/Seagen; GlaxoSmithKline; Merck; Myriad Genetics; Pfizer